103 related articles for article (PubMed ID: 32951506)
1. Estimating Downstream Budget Impacts in Implementation Research.
Wagner TH; Dopp AR; Gold HT
Med Decis Making; 2020 Nov; 40(8):968-977. PubMed ID: 32951506
[TBL] [Abstract][Full Text] [Related]
2. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
3. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
4. Estimating Costs of an Implementation Intervention.
Wagner TH; Yoon J; Jacobs JC; So A; Kilbourne AM; Yu W; Goodrich DE
Med Decis Making; 2020 Nov; 40(8):959-967. PubMed ID: 33078681
[TBL] [Abstract][Full Text] [Related]
5. Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries.
Orlewska E; Mierzejewski P
Value Health; 2004; 7(1):1-10. PubMed ID: 14720125
[TBL] [Abstract][Full Text] [Related]
6. Resolving the "Cost-Effective but Unaffordable" Paradox: Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts.
Lomas J; Claxton K; Martin S; Soares M
Value Health; 2018 Mar; 21(3):266-275. PubMed ID: 29566832
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
8. Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency.
Rueda JD; Sieluk J; Sandhaus RA; Mullins CD
Value Health Reg Issues; 2020 Dec; 23():70-76. PubMed ID: 32892111
[TBL] [Abstract][Full Text] [Related]
9. Rethinking How We Measure Costs in Implementation Research.
Wagner TH
J Gen Intern Med; 2020 Nov; 35(Suppl 2):870-874. PubMed ID: 33107005
[TBL] [Abstract][Full Text] [Related]
10. Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets.
Hofmeister M; Clement F
Int J Technol Assess Health Care; 2022 Jan; 38(1):e15. PubMed ID: 35080195
[TBL] [Abstract][Full Text] [Related]
11. Standardized Cost Estimates for Home Visiting: Pilot Study of the Home Visiting Budget Assistance Tool (HV-BAT).
Yarnoff B; Khavjou O; Bradley C; Leis J; Filene J; Honeycutt A; Herzfeldt-Kamprath R; Peplinski K
Matern Child Health J; 2019 Apr; 23(4):470-478. PubMed ID: 30547353
[TBL] [Abstract][Full Text] [Related]
12. [HAS budget impact analysis guidelines: A new decision-making tool].
Ghabri S; Poullié AI; Autin E; Josselin JM
Sante Publique; 2017 Oct; 29(4):585-588. PubMed ID: 29034674
[TBL] [Abstract][Full Text] [Related]
13. Budget-impact analyses: a critical review of published studies.
Orlewska E; Gulácsi L
Pharmacoeconomics; 2009; 27(10):807-27. PubMed ID: 19803537
[TBL] [Abstract][Full Text] [Related]
14. Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review.
Luo Z; Ruan Z; Yao D; Ung COL; Lai Y; Hu H
Front Public Health; 2021; 9():765999. PubMed ID: 34869180
[No Abstract] [Full Text] [Related]
15. Budget impact analysis: review of the state of the art.
Mauskopf JA; Earnshaw S; Mullins CD
Expert Rev Pharmacoecon Outcomes Res; 2005 Feb; 5(1):65-79. PubMed ID: 19807561
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for budget impact analysis of health technologies in Brazil].
Ferreira-Da-Silva AL; Ribeiro RA; Santos VC; Elias FT; d'Oliveira AL; Polanczyk CA
Cad Saude Publica; 2012 Jul; 28(7):1223-38. PubMed ID: 22729254
[TBL] [Abstract][Full Text] [Related]
17. Cost data in implementation science: categories and approaches to costing.
Gold HT; McDermott C; Hoomans T; Wagner TH
Implement Sci; 2022 Jan; 17(1):11. PubMed ID: 35090508
[TBL] [Abstract][Full Text] [Related]
18. The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).
Ghabri S; Autin E; Poullié AI; Josselin JM
Pharmacoeconomics; 2018 Apr; 36(4):407-417. PubMed ID: 29247437
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
